WATCH: Anti-aging, magnesium glycinate launches fuel Swisse’s H1 growth
Swisse has reported strong growth in its key markets of China, Australia and New Zealand for the first half of this year, with revenue up 5.8% from RMB$3.3bn (US$455.2m) to RMB$3.4bn (US$477.5m).
Growth was said to be led by what it said were innovations that have aligned with changing consumer preferences.
Examples of such innovations include beauty-from-within, anti-aging, magnesium glycinate supplements, and kids gummies.
S’pore, Malaysia offset Vita Life Sciences’ sales declines in China, Vietnam
Australia’s Vita Life Sciences has reported strong performance in Singapore and Malaysia, which has helped offset sales decline from China and Vietnam in the first half of this year.
Factors driving growth include stronger retailer collaboration and product expansion in key pharmacy chains in Singapore.
For the first six months of 2025, total revenue climbed 14% to AUD$45.5m (US$29.5m), while profit was up about 12% to 4.8m (US$3.1m).
a2MC doubles down on China label infant formula with new plant purchase
The a2 Milk Company (a2MC) is set to buy a manufacturing facility from Yashili New Zealand in the hopes of ramping up its China label infant formula business.
The company has been seeing sales growth for both its English and China label infant formula in FY25, with the former increased by 17.2% and the latter by 3.3%.
In China, growth was said to be led by effective new user recruitment initiatives, resulting in a record market share of 4% in stage 1 products in the mother-and-baby channels.
BYHEALTH profits down 17%, looks to SEA for new growth
China health supplements giant BYHEALTH has continued to see a decline in its sales and profits, and the company said it would be pumping more resources to grow its international business, especially in South East Asia.
Net profit attributed to shareholders of the company dropped 17.34% to RMB736.5m (US$102.5m), while operating revenue fell 23.43% to RMB 3.5bn (US$491.7m).
A continually fragmented retail landscape was said to be one of the reasons for the decline.
Haleon eyes growth opportunities in lower income markets
Haleon said it was banking on growth opportunities in lower income consumer segments such as India, and the Philippines, amid ongoing headwinds in the US market.
One of its recent launches for lower income consumers was Centrum Recharge - a multivitamin energy drink mix launched in India at 60 rupees (US$0.68) per box of six sachets.
Elsewhere in the Philippines, the company has expanded its reach to children from lower income families with Centrum Kids.
